Senores Pharmaceuticals Ltd (SENORES) — promoter pledge

Pledged promoter shares first appear in Senores Pharmaceuticals Ltd's Dec 2025 filing, covering 1.9% of promoter holding. The 2.8% pledged in Jun 2026 is the highest level on record. A year earlier, in Jun 2025, the figure was 0%. A pledge is reported in 3 of the 7 quarters of promoter shareholding data Solomo holds for this company.

2 members of the promoter group report pledged shares in Jun 2026: Espee Therapeutics LLP (1.07% of the company, 80.8% of it pledged), Mukur Yogeshkumar Barot (0.99% of the company, 42.2% of it pledged).

Ranked by share of promoter holding pledged, Senores Pharmaceuticals Ltd is #455 of the 563 listed Indian companies whose latest quarterly filing reports any pledged promoter shares.

A promoter pledge means a promoter has put their own shares up as collateral, usually against a loan. It is legal and common, and SEBI requires it to be disclosed every quarter in the shareholding pattern. It matters to other shareholders because a sharp fall in the share price can trigger a margin call: if the promoter cannot top up the collateral, the lender can invoke the pledge and sell those shares in the open market, which adds selling pressure to an already falling price and, at high pledge levels, can change who controls the company. The percentage on its own is not a verdict — the level, the direction of travel and what the borrowing funded all matter.